SOMA Research

What Is MOTS-c? A Research Guide to the Mitochondrial Peptide

MOTS-c is a 16-amino-acid peptide with an unusual provenance: it is not encoded in the nuclear genome. Its gene sits inside mitochondrial DNA, within the 12S ribosomal RNA gene, and it is one of a small family of peptides discovered by looking for open reading frames in a genome nobody expected to find them in. That origin is the most interesting thing about it and it has practical consequences for anyone working with the molecule.

SOMA Research supplies MOTS-c for laboratory research use only. It is not a drug, supplement, food or cosmetic, is not approved by the FDA for any use, and is not intended for human or veterinary consumption.

What MOTS-c is

  • Name: Mitochondrial Open reading frame of the Twelve S rRNA type-c
  • Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR)
  • CAS number: 1627580-64-6
  • Molecular formula: C101H152N28O22S2
  • Molecular weight: approximately 2,174.6 g/mol
  • Length: 16 amino acids
  • Appearance: white lyophilised powder

Encoded in mitochondrial DNA, which changes the genetic code

Mitochondria carry their own small circular genome, and that genome does not use the standard genetic code. Several codons are read differently inside a mitochondrion than they are in the cytoplasm — in the human mitochondrial code, AGA and AGG are stop codons rather than arginine, and ATA specifies methionine rather than isoleucine.

MOTS-c is read out of the 12S rRNA gene using that mitochondrial code. This is why the peptide was not found by conventional open-reading-frame searches: software applying the standard code to mitochondrial sequence produces a different translation and the reading frame does not resolve as a peptide at all. It belongs to a class now called mitochondrial-derived peptides, alongside humanin and the SHLP series.

For a researcher the practical consequence is specificity of comparison. A nuclear-encoded metabolic peptide and a mitochondrially encoded one are not interchangeable controls for each other, and the literature on MOTS-c is organised around mitochondrial biology rather than around receptor pharmacology, because no classical receptor defines it.

What the published research examines

  • AMPK signalling. The most frequently reported thread: activation of AMP-activated protein kinase in cell and rodent models, which places the compound in cellular energy-sensing rather than in receptor agonism.
  • Folate–methionine cycle. Work reporting effects on one-carbon metabolism, proposed as the upstream mechanism feeding into AMPK.
  • Metabolic phenotypes in rodents. Studies in diet and age models examining glucose handling and metabolic parameters.
  • Exercise and mitochondrial stress. Reports of changes in circulating levels under metabolic stress, used to argue for a signalling role between mitochondrion and nucleus.
  • Nuclear translocation. Work reporting the peptide moving to the nucleus under stress and associating with transcriptional regulation, which is the mechanistically distinctive claim in this literature.

All of it is preclinical. There is no approved human indication and no completed body of peer-reviewed human efficacy data. Research-grade MOTS-c is not a pharmaceutical product and claims about human outcomes are not supported by this evidence base.

Two oxidation-prone residues

The sequence carries features that matter more for handling than for biology:

  • Two methionines (positions 1 and 6). Methionine oxidises readily to the sulphoxide, adding 16 Da each. With two of them, a stored sample can show +16 and +32 Da species, and the mono-oxidised form can appear as two separate peaks because the two sites are chemically distinct. A trace showing a cluster of closely eluting peaks ahead of the main one is the expected signature of this, not necessarily a synthesis problem.
  • A tryptophan (position 3). Tryptophan is the most photosensitive of the standard amino acids and oxidises under light exposure. Combined with the methionines, MOTS-c is among the less forgiving peptides in the catalogue to store badly.
  • Two tyrosines, which give the peptide useful UV absorbance around 280 nm for concentration estimation alongside the tryptophan.

Light protection is therefore not boilerplate for this compound. Amber vials, minimal bench time, small aliquots.

Analytical characterisation

  • HPLC purity. Reversed-phase separation; expect the oxidation-related species discussed above to be the main resolvable impurities on an aged lot, distinct from synthesis deletions.
  • Mass spectrometry. Identity against approximately 2,174.6 g/mol. At this mass electrospray gives a multiply charged envelope and the reported figure is a deconvoluted mass.
  • Three arginines and a lysine make the peptide strongly basic, so it is supplied as a salt and the counter-ion contributes to weighed mass. Read peptide content separately from HPLC purity — the Certificate of Analysis guide covers the difference.

Every SOMA lot is tested by third-party laboratories using both methods, with measured figures published per lot in our CoA library.

Handling and storage

  • Lyophilised powder: -20°C, protected from light — non-negotiable here because of the tryptophan.
  • Reconstituted stock: 2–8°C, aliquoted, used within approximately 30 days.
  • Minimise oxygen and light exposure of solutions. Keep headspace small, keep vials closed, do not leave working solutions standing on the bench.
  • Avoid oxidising agents in buffers.
  • Avoid freeze-thaw cycling.

The general procedure and the concentration arithmetic are in our reconstitution guide.

Research use only

Research-grade MOTS-c is supplied for laboratory use by qualified researchers and institutions. It is not manufactured to pharmaceutical standards, has not been approved by the FDA for any use, and must not be used in or on humans or animals. Nothing in this guide is medical advice or a representation that the compound is safe or effective for any purpose.